115 related articles for article (PubMed ID: 38263583)
21. Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies.
Xu Y; Fang W; Zeng W; Leijen S; Woolf EJ
Anal Bioanal Chem; 2012 Dec; 404(10):3037-48. PubMed ID: 23099526
[TBL] [Abstract][Full Text] [Related]
22. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
[TBL] [Abstract][Full Text] [Related]
23. Novel high-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton's tyrosine kinase inhibitors and their three active metabolites in human plasma.
Mukai Y; Yoshida T; Kondo T; Inotsume N; Toda T
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121928. PubMed ID: 31877431
[TBL] [Abstract][Full Text] [Related]
24. Metabolism and pharmacokinetic study of deuterated osimertinib.
Zhan X; Bao S; Li X; Zhou S; Dahar MR; Lin N; Chen X; Niu C; Ji K; Wu Y; Zeng K; Tang Z; Yu L
Biopharm Drug Dispos; 2023 Apr; 44(2):165-174. PubMed ID: 36649539
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS/MS in human plasma and its application to therapeutic drug monitoring in cancer patients.
Zhao J; Yan D; Li Y; Xu X; Li F; Zhang S; Jin J; Qiu F
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124100. PubMed ID: 38547701
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of dried blood spots as an alternative sampling strategy for 5-fluorouracil monitoring: From method development to clinical application.
da Silva LC; Grando AP; de Baco LS; Hahn RZ; Ferreira Filho AF; Brucker N; Linden R; Antunes MV
J Pharm Biomed Anal; 2023 Oct; 235():115539. PubMed ID: 37517245
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous online SPE-HPLC-MS/MS quantification of gefitinib, osimertinib and icotinib in dried plasma spots: Application to therapeutic drug monitoring in patients with non-small cell lung cancer.
Jia M; Wu Z; Shi W; Wang S; Huang X; Zhang M; Bao W; Bao A; Zhang P; Ding F; Xie G; Lou Y; Fan G
J Pharm Biomed Anal; 2023 May; 228():115275. PubMed ID: 36871365
[TBL] [Abstract][Full Text] [Related]
28. Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.
Aghai-Trommeschlaeger F; Zimmermann S; Gesierich A; Kalogirou C; Goebeler ME; Jung P; Pelzer T; Kurlbaum M; Klinker H; Isberner N; Scherf-Clavel O
Clin Biochem; 2022; 105-106():35-43. PubMed ID: 35483452
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous quantitative detection of afatinib, erlotinib, gefitinib, icotinib, osimertinib and their metabolites in plasma samples of patients with non-small cell lung cancer using liquid chromatography-tandem mass spectrometry.
Xiong X; Zhang Y; Wang Z; Zhou C; Yang P; Du X; Yang L; Liu W
Clin Chim Acta; 2022 Feb; 527():1-10. PubMed ID: 34999058
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous determination of alflutinib and its active metabolite in human plasma using liquid chromatography-tandem mass spectrometry.
Liu X; Li W; Zhang Y; Jiang Y; Zhao Q; Zhong D
J Pharm Biomed Anal; 2019 Nov; 176():112735. PubMed ID: 31394305
[TBL] [Abstract][Full Text] [Related]
31. Quantification of rifapentine, a potent antituberculosis drug, from dried blood spot samples using liquid chromatographic-tandem mass spectrometric analysis.
Parsons TL; Marzinke MA; Hoang T; Bliven-Sizemore E; Weiner M; Mac Kenzie WR; Dorman SE; Dooley KE
Antimicrob Agents Chemother; 2014 Nov; 58(11):6747-57. PubMed ID: 25182637
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a liquid chromatography-tandem mass spectrometry assay for nine oral anticancer drugs in human plasma.
Janssen JM; de Vries N; Venekamp N; Rosing H; Huitema ADR; Beijnen JH
J Pharm Biomed Anal; 2019 Sep; 174():561-566. PubMed ID: 31255856
[TBL] [Abstract][Full Text] [Related]
33. Dried Blood Spots Combined With Ultra-High-Performance Liquid Chromatography-Mass Spectrometry for the Quantification of the Antipsychotics Risperidone, Aripiprazole, Pipamperone, and Their Major Metabolites.
Tron C; Kloosterboer SM; van der Nagel BCH; Wijma RA; Dierckx B; Dieleman GC; van Gelder T; Koch BCP
Ther Drug Monit; 2017 Aug; 39(4):429-440. PubMed ID: 28700523
[TBL] [Abstract][Full Text] [Related]
34. Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.
Knippenberg B; Page-Sharp M; Salman S; Clark B; Dyer J; Batty KT; Davis TM; Manning L
Antimicrob Agents Chemother; 2016 Aug; 60(8):4940-55. PubMed ID: 27270283
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients.
Dillenburg Weiss TL; Gössling G; Venzon Antunes M; Schwartsmann G; Linden R; Gasparin Verza S
J Pharm Biomed Anal; 2021 Feb; 195():113861. PubMed ID: 33373824
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of a Dried Blood Spot Assay Using UHPLC-MS/MS to Identify and Quantify 12 Antihypertensive Drugs and 4 Active Metabolites: Clinical Needs and Analytical Limitations.
Peeters LEJ; Bahmany S; Dekker T; Aliawi A; van Domburg B; Versmissen J; Koch BCP
Ther Drug Monit; 2022 Aug; 44(4):568-577. PubMed ID: 35383727
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous determination of fluoxetine and norfluoxetine in dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.
da Silva ACC; Raasch JR; Vargas TG; Peteffi GP; Hahn RZ; Antunes MV; Perassolo MS; Linden R
Clin Biochem; 2018 Feb; 52():85-93. PubMed ID: 28987790
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of a LC-MS/MS Method for Quantification of Mobocertinib (TAK-788) in Plasma and its Application to Pharmacokinetic Study in Rats.
Li B; Wang J; Dou X; Zhang X; Xue X; Xu Q; Ran W; Xiong S
Comb Chem High Throughput Screen; 2021; 24(9):1410-1416. PubMed ID: 33155888
[TBL] [Abstract][Full Text] [Related]
39. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry.
Ansari M; Uppugunduri CR; Déglon J; Théorêt Y; Versace F; Gumy-Pause F; Ozsahin H; Dayer P; Desmules J; Daali Y
Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1437-46. PubMed ID: 22592987
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Dried Blood Spots Versus Conventional Plasma Collection for the Characterization of Efavirenz Pharmacokinetics in a Large-Scale Global Clinical Trial-The ENCORE1 Study.
Amara AB; Else LJ; Carey D; Khoo S; Back DJ; Amin J; Emery S; Puls RL
Ther Drug Monit; 2017 Dec; 39(6):654-658. PubMed ID: 28953037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
